Munich - Delayed Quote EUR
Aurora Cannabis Inc (21P.MU)
4.9050
-0.0250
(-0.51%)
At close: May 30 at 8:01:17 AM GMT+2
Loading Chart for 21P.MU
- Previous Close
4.9300 - Open
4.9050 - Bid 4.6500 x --
- Ask 4.6900 x --
- Day's Range
4.9050 - 4.9050 - 52 Week Range
3.3750 - 6.4500 - Volume
0 - Avg. Volume
158 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Jun 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 21P.MU
View MorePerformance Overview: 21P.MU
Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
21P.MU
20.52%
S&P/TSX Composite index (^GSPTSE)
6.31%
1-Year Return
21P.MU
14.99%
S&P/TSX Composite index (^GSPTSE)
18.59%
3-Year Return
21P.MU
70.62%
S&P/TSX Composite index (^GSPTSE)
25.12%
5-Year Return
21P.MU
96.15%
S&P/TSX Composite index (^GSPTSE)
72.29%
Compare To: 21P.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
4.9050
-0.51%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.6050
-0.82%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.1600
-1.69%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0060
+20.00%
Mkt Cap EUR 2.514M
Industry Drug Manufacturers—Specialty & Generic
0.1970
0.00%
Mkt Cap EUR 64.097M
Industry Drug Manufacturers—Specialty & Generic
0.0700
+9.37%
Mkt Cap EUR 14.137M
Industry Drug Manufacturers—Specialty & Generic
0.6050
-2.42%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.6180
-0.25%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.5600
-1.75%
Mkt Cap EUR 14.044M
Industry Drug Manufacturers—Specialty & Generic
3.4360
-4.29%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0880
+8.64%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: 21P.MU
View MoreValuation Measures
As of 5/30/2025
Market Cap
254.01M
Enterprise Value
249.09M
Trailing P/E
28.54
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.32
Price/Book (mrq)
0.74
Enterprise Value/Revenue
1.22
Enterprise Value/EBITDA
7.80
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--